Incidence, risk factors and treatment response in patients with chronic graft versus-host disease after haploidentical transplantation with post-transplantation cyclophosphamide

被引：0
|
作者：
Rivera, Daniel [1 ]
Lopez-Corral, Lucia [1 ]
Kwon, Mi [2 ]
Bermudez, Arancha [3 ]
Yanez, Lucrecia [3 ]
Gallardo, Anabel [4 ]
Cabrero, Monica [1 ]
Champ, Diana [2 ]
Garcia-Avila, Sara [3 ]
Garcia, Abel [4 ]
Perez, Estefania [1 ]
Balsalobre, Pascual [2 ]
Colorado, Mercedes [3 ]
Jesus Pascual, Maria [4 ]
Martin, Ana [1 ]
Luis Diez, Jose [2 ]
Gayoso, Jorge [2 ]
Dolores Caballero, Maria [1 ]
机构：
[1] Hosp Univ Salamanca IBSAL, Hematol, Salamanca, Spain
[2] Hosp 12 Octubre, Hematol, Madrid, Spain
[3] Hosp Marques Valdecilla, Hematol, Santander, Spain
[4] Hosp Carlos Haya, Hematol, Malaga, Spain
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P374
引用
收藏
页码：426 / 427
页数：2
相关论文
共 50 条
  • [21] POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGHER-RISK MYELODYSPLASTIC SYNDROME
    Choi, E. -J.
    Park, H. -S.
    Lee, J. -H.
    Lee, K. -H.
    Lee, J. -H.
    [J]. LEUKEMIA RESEARCH, 2021, 108 : S49 - S49
  • [22] Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Higher-Risk Myelodysplastic Syndrome
    Choi, Eun-Ji
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Kyoo Hyung
    Lee, Youngshin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Lee, Je-Hwan
    [J]. BLOOD, 2021, 138
  • [23] Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Hammerstrom, Aimee E.
    Alousi, Amin
    Qazilbash, Muzaffar
    Bashir, Qaiser
    Ahmed, Sairah
    Popat, Uday
    Hosing, Chitra
    Khouri, Issa
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Ciurea, Stefan O.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (03) : 444 - 455
  • [24] Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Rondon, Gabriela
    Al-Atrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra M.
    Kebriaei, Partow
    Khouri, Issa
    Nieto, Yago
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Srour, Samer A.
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Alousi, Amin M.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 695.e1 - 695.e10
  • [25] Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus
    Ashouri, Karam
    Fernandez, Eduardo
    Ginosyan, Anush
    Feliciano, Carissa M.
    Hom, Brian
    Rodman, Jack
    Ali, Amir
    Ladha, Abdullah
    Woan, Karrune
    Tam, Eric
    Chaudhary, Preet
    Yaghmour, George
    [J]. TRANSPLANTATION PROCEEDINGS, 2024, 56 (07) : 1 - 7
  • [26] POST-TRANSPLANTATION CYCLOPHOSPHAMIDE AND MESENCHYMAL STEM CELLS INFUSION FOR GRAFT-VERSUS-HOST PROPHYLAXIS FOR PATIENTS WITH ADVANCED DISEASE AFTER ALLOGENIC BONE MARROW TRANSPLANTATION
    Savchenko, V.
    Parovichnikova, E.
    Kuzmina, L.
    Drokov, M.
    Vasilyeva, V.
    Pokrovskaya, O.
    Mendeleeva, L.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S554 - S554
  • [27] Post-Transplantation Cyclophosphamide and Mesenchymal Stem Cells Infusion For Graft-Versus-Host Prophylaxis For Patients With Advanced Disease After Allogenic Bone Marrow Transplantation
    Drokov, Mikhail
    Parovichnikova, Elena
    Kuzmina, Larisa
    Vasilyeva, Vera
    Karyakina, Alexandra
    Galstian, Gennadyi
    Savchenko, Valeri G.
    [J]. BLOOD, 2013, 122 (21)
  • [28] Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia
    Paul, Suman
    Tsai, Hua-Ling
    Lowery, Patrick
    Fuchs, Ephraim J.
    Luznik, Leo
    Bolanos-Meade, Javier
    Swinnen, Lode J.
    Shanbhag, Satish
    Wagner-Johnston, Nina
    Varadhan, Ravi
    Ambinder, Richard F.
    Jones, Richard J.
    Gladstone, Douglas E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : 502 - 508
  • [29] RESULTS OF THE HAPLOIDENTICAL BONE MARROW TRANSPLANTATION WITH CYCLOPHOSPHAMIDE POST TRANSPLANTATION AND EARLY WITHDRAWAL OF IMMUNOSUPPRESSION: IMPACT ON GRAFT VERSUS HOST DISEASE
    Garcia Avila, S.
    Cabero Martinez, A.
    Richard Espiga, C.
    Yanez San Segundo, L.
    Colorado Araujo, M.
    Lopez Duarte, M.
    Insunza Gaminde, A.
    Romon Alonso, I
    Sanchez Escamilla, M.
    Arroyo, J. L.
    Nunez Cespedes, J.
    Montes Gaisan, C.
    Celis Alvarez, M.
    Fernandez Martinez, C.
    Bermudez Rodriguez, A.
    [J]. HAEMATOLOGICA, 2017, 102 : 205 - 206
  • [30] Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis
    D. Ruttens
    P. Philippet
    G. Bucciol
    I. Meyts
    [J]. Journal of Clinical Immunology, 2023, 43 : 1758 - 1765
12345